Every summer, the Steffens Scleroderma Foundation hosts a Cruise for the Cure fundraising event. There aren’t too many better ways to spend a summer afternoon than out on a boat, cruising down the historic Hudson River, enjoying drinks and delicious food, and raising money for a great cause! 

2021 Cruise for a Real Cure was a great success!!

Thank you all who participated and donated to the cruise.

• Dutch Apple Cruises 

• DeMarco's Italian Restaurant

• Planet Believe

• Ellms Family Farms

• USS Slater

• Tri-City Valley Cats

• Fred Astaire Dance Studio

• 1^st National Bank

• Sweet Willey’s

• Snowman’s Ice Cream

• Oriental Trading Company

• Casa Visco

• CVS

• Advance Auto Parts

• Parkway Liquor

2020 Virtual Cruise for a Real Cure was Held Sunday, July 12, 2020

Due to the pandemic and the need for social distancing, the annual cruise went virtual in 2020! More than 100 participants took a virtual ride on the Hudson River to raise awareness and funding for scleroderma and Degos disease research and education. Along the way they heard from U.S. Congressman Paul Tonko who  provided an udpate on his proposed legislation, the Helping Experts Accelerate Rare Treatments (HEART) Act, that aims to strengthen the review of rare disease treatment.  Dr. Lee Shapiro also spoke about the foundation's efforts to improve the patient experience for those facing scleroderma and Degos disease by educating healthcare providers and supporting collaboration among researchers. And winners were announced for the event raffle and online auction. 

Event Sponsors

We’re grateful to our event sponsors Dutch Apple Cruises, DeMarco's Restaurant, and the Renna family for their continued generosity in memory of Lou Renna who lost his battle with scleroderma. Special thanks to Planet Believe for providing custom event t-shirts for participants!

Thank you so much to all that participated in the 2023 Cruise for a Real Cure. We are grateful to all that made the event possible! We look forward to cruising the way to a real cure for scleroderma and Degos disease in 2024.